Literature DB >> 20346070

The International Normalized Ratio (INR) in the MELD score: problems and solutions.

R J Porte1, T Lisman, A Tripodi, S H Caldwell, J F Trotter.   

Abstract

The Model for End-Stage Liver Disease (MELD) score is widely used to prioritize patients for liver transplantation. One of the pitfalls of the MELD score is the interlaboratory variability in all three components of the score (INR, bilirubin, creatinine). The interlaboratory variability in the INR has the largest impact on the MELD score, with a mean difference of around 5 MELD points in most studies. During the 3rd conference on Coagulopathy and Liver disease, a multidisciplinary group of scientists and physicians discussed possible solutions for the INR problem in the MELD score with the intention to provide a constructive contribution to the international debate on this issue. Here we will discuss possible solutions and highlight advantages and disadvantages.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20346070     DOI: 10.1111/j.1600-6143.2010.03064.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  19 in total

1.  The validity of the INR system for patients with liver disease.

Authors:  Armando Tripodi
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

Review 2.  Prioritization for liver transplantation.

Authors:  Evangelos Cholongitas; Giacomo Germani; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

3.  Medical and endoscopic management of gastric varices.

Authors:  Abdullah M S Al-Osaimi; Stephen H Caldwell
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

4.  Simplified model for end-stage liver disease score predicts mortality for tricuspid valve surgery.

Authors:  Kazumasa Tsuda; Masaaki Koide; Yoshifumi Kunii; Kazumasa Watanabe; Satoshi Miyairi; Yuko Ohashi; Takashi Harada
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-12

Review 5.  Model for end-stage liver disease: end of the first decade.

Authors:  Sumeet K Asrani; W Ray Kim
Journal:  Clin Liver Dis       Date:  2011-10-01       Impact factor: 6.126

Review 6.  Changing Concepts of Cirrhotic Coagulopathy.

Authors:  Armando Tripodi; Massimo Primignani; Pier M Mannucci; Stephen H Caldwell
Journal:  Am J Gastroenterol       Date:  2016-11-01       Impact factor: 10.864

Review 7.  Model for end-stage liver disease score and MELD exceptions: 15 years later.

Authors:  Sumeet K Asrani; Patrick S Kamath
Journal:  Hepatol Int       Date:  2015-05-28       Impact factor: 6.047

8.  Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma.

Authors:  Qing Lei; Yinhua Zhang; Changzheng Ke; Chunchun Yan; Ping Huang; Haixia Shen; Huiting Lei; Yue Chen; Jie Luo; Zhongji Meng
Journal:  Exp Ther Med       Date:  2018-01-12       Impact factor: 2.447

9.  The corneal transplant score: a simple corneal graft candidate calculator.

Authors:  Eldar Rosenfeld; David Varssano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-07       Impact factor: 3.117

10.  Usefulness of International Normalized Ratio to Albumin Ratio for Evaluation of Mortality in Hepatitis B Virus-Associated Decompensated Cirrhosis.

Authors:  Ming Cai; Zhong Han; Xia He; JinFei Zhang
Journal:  Biomed Res Int       Date:  2021-05-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.